- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Unusual Options Trading Targets Bristol Myers Squibb
Traders purchased 66,895 call options on the pharmaceutical company's stock, an 81% increase over the average volume.
Apr. 1, 2026 at 7:56pm
Got story updates? Submit your updates here. ›
Bristol Myers Squibb Company (NYSE:BMY) saw a significant spike in call options trading on Wednesday, with traders purchasing 66,895 call options - an 81% increase compared to the average daily volume of 37,032 call options. This unusual options activity suggests heightened investor interest and potential bullish sentiment around the pharmaceutical company's stock.
Why it matters
Unusual options trading activity can signal that investors are anticipating significant stock price movements, either up or down. In the case of Bristol Myers Squibb, the surge in call option purchases suggests traders are betting on the stock price increasing, potentially due to positive news or developments related to the company's drug pipeline, financial performance, or other factors.
The details
The call options trading volume of 66,895 represents an 81% increase over the average daily volume of 37,032 call options on Bristol Myers Squibb's stock. This unusually high options activity indicates that traders are positioning themselves for potential upside in the stock price, though the specific reasons behind the trading are not entirely clear from the available information.
- The unusual options trading activity occurred on Wednesday, April 1, 2026.
The players
Bristol Myers Squibb Company
A global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing, and delivering medicines for serious diseases.
The takeaway
The surge in call options trading on Bristol Myers Squibb's stock suggests that investors are anticipating positive developments for the company, though the specific reasons behind the heightened activity are not yet known. This unusual options trading activity could signal an impending stock price movement, either up or down, and warrants further monitoring and analysis.
